Skip to content
WeighLab

Kova vs Näky

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Kova

Provider comparison

Shoppers willing to commit to a longer plan to bring compounded semaglutide down toward $129 a month, with an app that tracks protein and side effects.

Semaglutide / month
$299/moMonth to month, compounded
Tirzepatide / month
$399/moMonth to month, compounded
Index 73/100 · Grade CChecked October 2026

Näky

Provider comparison

Shoppers comparing compounded injections with brand-name oral GLP-1 options and published plan-length prices.

Semaglutide / month
$185/moMonth to month, any dose, compounded
Tirzepatide / month
$295/moMonth to month, any dose, compounded
Index 72/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Kova has the higher Cost-Efficiency Index: 73/100 versus 72/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

Kova
All 50 states
Näky
Coverage not published

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Kova

Näky

Semaglutide / month
Kova: $299/moMonth to month, compounded
Näky: $185/moMonth to month, any dose, compounded
Tirzepatide / month
Kova: $399/moMonth to month, compounded
Näky: $295/moMonth to month, any dose, compounded
Semaglutide / year (modeled)
Kova: $3,588
Näky: $2,220
Tirzepatide / year (modeled)
Kova: $4,788
Näky: $3,540
State availability
Kova: All 50 states
Näky: Coverage not published
Oral / sublingual option listed
Kova: Not listed
Näky: Yes
Brand-name access listed
Kova: Not confirmed
Näky: Yes
Provider facts checked
Kova: October 2026
Näky: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Kova

Shoppers willing to commit to a longer plan to bring compounded semaglutide down toward $129 a month, with an app that tracks protein and side effects.

Reasons to consider it

  • Semaglutide drops from $299 a month to $179, $149 and $129 on 3-, 6- and 12-month plans, all listed before you start
  • You aren't charged unless a clinician approves treatment
  • Names its prescribers, led by Dr. Laurie Mercier, and five compounding pharmacies, including Strive and Southend

What to weigh up

  • Month to month is the dearest way to buy: $299 for semaglutide and $399 for tirzepatide after the first month
  • The $129 to $179 semaglutide rates require a 3-, 6- or 12-month commitment
  • Lab work isn't included; if your clinician orders it, you pay for it separately

Näky

Shoppers comparing compounded injections with brand-name oral GLP-1 options and published plan-length prices.

Reasons to consider it

  • Brand-name Wegovy and Foundayo pills are offered separately from compounded injections, with the dose prices and additional membership shown
  • Separate semaglutide and tirzepatide microdose programs are listed; ask the prescriber which treatment fits
  • LegitScript verification is displayed and checkable for its own website

What to weigh up

  • The advertised $145 semaglutide and $265 tirzepatide rates require six months prepaid; month-to-month rates are $185 and $295
  • Brand-name pill prices exclude a required $125 monthly membership; add it to the dose-specific medication charge
  • Naky Health LLC is named, but its state list, dispensing pharmacies and medical director are not published

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

KovaNäky
Normalized Cost/Month
Kova:
46/100
Näky:
80/100
Price Transparency
Kova:
92/100
Näky:
94/100
Nationwide Access
Kova:
86/100
Näky:
24/100
Formulation Options
Kova:
66/100
Näky:
90/100
Clinical Oversight
Kova:
76/100
Näky:
81/100
Contract Flexibility
Kova:
77/100
Näky:
55/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.